Cerebral microvascular inflammation in DOCA salt-induced hypertension: Role of angiotensin II and mitochondrial superoxide

Journal of Cerebral Blood Flow and Metabolism

Volumn 32, Issue 2, 2012, Pages 368-375

  Rodrigues, Stephen F ^a   Granger, Daniel Neil ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

angiotensin II; blood cells; cerebral venules; DOCA salt induced hypertension; ROS; stroke

Indexed keywords

ANGIOTENSIN II; ANTIOXIDANT; DEOXYCORTICOSTERONE ACETATE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 6; LOSARTAN; MITO TEMPO; MONOCYTE CHEMOTACTIC PROTEIN 1; OXYGEN RADICAL; REACTIVE OXYGEN METABOLITE; TEMPOL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BLOOD PRESSURE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN WATER; CELL INTERACTION; CONTROLLED STUDY; ENCEPHALITIS; HYPERTENSION; LEUKOCYTE ADHERENCE; MALE; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALT INDUCED HYPERTENSION; THROMBOCYTE ADHESION; VENULE;

ANGIOTENSIN II; ANIMALS; BLOOD PLATELETS; BLOOD PRESSURE; BRAIN; CELL ADHESION; CYTOKINES; DESOXYCORTICOSTERONE; HYPERTENSION; LEUKOCYTES; MALE; MICE; MICE, INBRED C57BL; MICROVESSELS; MINERALOCORTICOIDS; MITOCHONDRIA; REACTIVE OXYGEN SPECIES; STROKE; SUPEROXIDES;

EID: 84856444236     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2011.139     Document Type: Article

References (30)

1. Arumugam TV, Salter JW, Chidlow JH, Ballantyne CM, Kevil CG, Granger DN (2004) Contributions of LFA-1 and Mac-1 to brain injury and microvascular dysfunction induced by transient middle cerebral artery occlusion. Am J Physiol Heart Circ Physiol 287: H2555-60 (Pubitemid 39557124)
2. Basso N, Ruiz P, Mangiarua E, Taquini AC (1981) Renin-like activity in the rat brain during the development of DOCsalt hypertension. Hypertension 3(Suppl II): II14-7
3. Bird JE, Moreland S, Waldron TL, Powell JR (1995) Antihypertensive effects of a novel endothelin-A receptor antagonist in rats. Hypertension 25:1191-5
4. Coyle P, Jokelainen PT (1983) Differential outcome to middle cerebral artery occlusion in spontaneously hypertensive stroke-prone rats (SHRSP) and Wistar Kyoto (WKY) rats. Stroke 14:605-11 (Pubitemid 13036791)
5. Crofton JT, Share L, Shade RE, Lee-Kwon WJ, Manning M, Sawyer WH (1979) The importance of vasopressin in the development and maintenance of DOC-salt hypertension in the rat. Hypertension 1:31-8
6. Dai DF, Chen T, Szeto H, Nieves-Cintrón M, Kutyavin V, Santana LF, Rabinovitch PS (2011) Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy. J Am Coll Cardiol 58:73-82
7. Dai DF, Rabinovitch P (2011) Mitochondrial oxidative stress mediates induction of autophagy and hypertrophy in angiotensin-II treated mouse hearts. Autophagy 7:917-8
8. Dogan A, Başkaya MK, Rao VL, Rao AM, Dempsey RJ (1998) Intraluminal suture occlusion of the middle cerebral artery in Spontaneously Hypertensive rats. Neurol Res 20:265-70 (Pubitemid 28180803)
9. Fleegal-DeMotta MA, Doghu S, Banks WA (2009) Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells. J Cereb Blood Flow Metab 29:640-7
10. Fournie-Zaluski MC, Fassot C, Valentin B, Djordjijevic D, Reaux-Le Goazigo A, Corvol P, Roques BP, Llorens-Cortes C (2004) Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension. Proc Natl Acad Sci USA 101:7775-80 (Pubitemid 38678554)
11. Herd CM, Page CP (1994) Pulmonary immune cells in health and disease: platelets. Eur Respir J 7:1145-60 (Pubitemid 24187337)
12. Ishikawa M, Sekizuka E, Yamaguchi N, Nakadate H, Terao S, Granger DN, Minamitani H (2007) Angiotensin II type 1 receptor signaling contributes to plateletleukocyte-endothelial cell interactions in the cerebral microvasculature. Am J Physiol Heart Circ Physiol 292:H2306-15 (Pubitemid 47084612)
13. Ishikawa M, Vowinkel T, Stokes KY, Arumugam TV, Yilmaz G, Nanda A, Granger DN (2005) CD40/CD40 ligand signaling in mouse cerebral microvasculature after focal ischemia/reperfusion. Circulation 111: 1690-6 (Pubitemid 40525171)
14. Lin TN, He YY, Wu G, Khan M, Hsu CY (1993) Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 24:117-21 (Pubitemid 23014393)
15. Möhring J, Möhring B, Petri M, Haack D (1976) Is vasopressin involved in the pathogenesis of malignant deoxycorticosterone hypertension in rats? Lancet 1:170-3
16. Reid JL, Zivin JA, Kopin IJ (1975) Central and peripheral adrenergic mechanisms in the development of deoxycorticosterone-saline hypertension in rats. Circ Res 37:569-79
17. Somers MJ, Mavromatis K, Galis ZS, Harrison DG (2000) Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation 101:1722-8 (Pubitemid 30196634)
18. Suzuki K, Sugimura K, Hasegawa K, Yoshida K, Suzuki A, Ishizuka K, Ohtsuka K, Honma T, Narisawa R, Asakura H (2001) Activated platelets in ulcerative colitis enhance the production of reactive oxygen species by polymorphonuclear leukocytes. Scand J Gastroenterol 36:1301-6 (Pubitemid 33027810)
19. Tureyen K, Kapadia R, Bowen KK, Satriotomo I, Liang J, Feinstein DL, Vemuganti R (2007) Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. J Neurochem 101:41-56 (Pubitemid 46426485)
20. Turnbull F, Blood Pressure Lowering Treatment Trialists' Collaboration (2003) Effects of different blood-pressurelowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 362:1527-35
21. Uyama O, Okamura N, Yanase M, Narita M, Kawabata K, Sugita M (1988) Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. J Cereb Blood Flow Metab 8:282-4 (Pubitemid 18079698)
22. Vinh A, Chen W, Blinder Y, Weiss D, Taylor WR, Goronzy JJ, Weyand CM, Harrison DG, Guzik TJ (2010) Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension. Circulation 122:2529-37
23. Vital SA, Terao S, Nagai M, Granger DN (2010) Mechanisms underlying the cerebral microvascular responses to angiotensin II-induced hypertension. Microcirculation 17:641-9
24. Wang Q, Hummler E, Nussberger J, Clément S, Gabbiani G, Brunner HR, Burnier M (2002) Blood pressure, cardiac, and renal responses to salt and deoxycorticosterone acetate in mice: role of Renin genes. J Am Soc Nephrol 13:1509-16 (Pubitemid 34579240)
25. Werber AH, Fitch-Burke MC (1988) Effect of chronic hypertension on acute hypertensive disruption of the blood-brain barrier in rats. Hypertension 12:549-55 (Pubitemid 19030499)
26. WHO (2002) The World Health Report 2002-Reducing Risks, Promoting Healthy Life. Geneva: WHO. Available from http://www.who.int/whr/2002/en/
27. Yemane H, Busauskas M, Burris SK, Knuepfer MM (2010) Neurohumoral mechanisms in deoxycorticosterone acetate (DOCA)-salt hypertension in rats. Exp Physiol 95:51-5
28. Yilmaz G, Granger DN (2010) Leukocyte recruitment and ischemic brain injury. Neuromol Med 12:193-204
29. Zhang M, Mao Y, Ramirez SH, Tuma RF, Chabrashvili T (2010) Angiotensin II induced cerebral microvascular inflammation and increased blood-brain barrier permeability via oxidative stress. Neuroscience 171:852-8
30. Zheng Z, Lee JE, Yenari MA (2003) Stroke: Molecular mechanisms and potential targets for treatment. Curr Mol Med 3:361-72 (Pubitemid 36621793)